“PROCAM based myocardial infarction risk in relation to global vascular disease risk: observations from the ARCO cohort study”, Swiss Med Wkly, vol. 152, no. 0708, p. w30111, Feb. 2022, doi: 10.4414/SMW.2022.w30111.